Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Reinhardt

Showing results (111-120 of 236) with videos related to

Pageof 24
Sort By:
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Frontiers in Oncology|October 8, 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspectiveAnn-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, et al.
Human Molecular Genetics|October 3, 2012
The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZSandra Habbig, Malte P Bartram, Josef G Sägmüller, et al.
Science Translational Medicine|June 14, 2013
Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumorsArina Riabinska, Mathias Daheim, Grit S Herter-Sprie, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Journal of the American Society of Nephrology : JASN|July 4, 2008
KIBRA modulates directional migration of podocytesKerstin Duning, Eva-Maria Schurek, Marc Schlüter, et al.
Nature|March 16, 2007
14-3-3sigma controls mitotic translation to facilitate cytokinesisErik W Wilker, Marcel A T M van Vugt, Steven A Artim, et al.
Leukemia|August 21, 2019
The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximabKarl-Anton Kreuzer, Richard R Furman, Stephan Stilgenbauer, et al.
Bone Marrow Transplantation|July 11, 2021
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMTFrédéric Baron, Maud Ngoya, Myriam Labopin, et al.
Pageof 24

Showing results (111-120 of 236) with videos related to

Sort By:
Pageof 24
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Frontiers in Oncology|October 8, 2024
How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspectiveAnn-Cathrine Siefen, Melina Sophie Kurte, Florian Jakobs, et al.
Human Molecular Genetics|October 3, 2012
The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZSandra Habbig, Malte P Bartram, Josef G Sägmüller, et al.
Science Translational Medicine|June 14, 2013
Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumorsArina Riabinska, Mathias Daheim, Grit S Herter-Sprie, et al.
Blood Advances|January 20, 2022
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisNico Gagelmann, Christine Wolschke, Rachel B Salit, et al.
Journal of the American Society of Nephrology : JASN|July 4, 2008
KIBRA modulates directional migration of podocytesKerstin Duning, Eva-Maria Schurek, Marc Schlüter, et al.
Nature|March 16, 2007
14-3-3sigma controls mitotic translation to facilitate cytokinesisErik W Wilker, Marcel A T M van Vugt, Steven A Artim, et al.
Leukemia|August 21, 2019
The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximabKarl-Anton Kreuzer, Richard R Furman, Stephan Stilgenbauer, et al.
Bone Marrow Transplantation|July 11, 2021
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMTFrédéric Baron, Maud Ngoya, Myriam Labopin, et al.
Pageof 24